Posts in category

Clinical


TGA releases list of Ranitidine products impacted by recall  Ranitidine tablets and oral liquids are now in short supply as a number of commonly-used brands have been recalled from pharmacies, …

A study across patients recruited from Australian community pharmacies has looked at the link between prescribed opioid dose and problematic behaviours Many people stay on opioids for years to treat …

A look back at some of the ‘health misadventures’ common in the earlier years of the 20th century, by Ralph Tapping  Health follies’ of the last century might otherwise be …

A BMJ review of e-cigarettes’ effects shows concerning results including higher rates of acute respiratory illness, acute injury to the small airways and immunosuppression Studies show e-cigarettes have measurable adverse …

Decision on PPI double dosing deferred by PBAC, but support given to antibiotic listing changes The Pharmaceutical Benefits Advisory Committee (PBAC) has deferred a decision on whether to allow twice …

A systematic review has identified areas of pharmacy-related research that were not conducted to the highest standard or where reporting is inadequate Improvements can be made to pharmacy research practice …

Restrictions on alprazolam prescribing have failed to curb usage, with sales of bigger packs on the increase  Measures introduced in 2017 to prevent potentially harmful usage of alprazolam have failed …

People with medical conditions such as asthma, COPD, arthritis, cancer and depression are more likely to report marijuana use, according to a new study A large US study has looked …

New fixed-dosed two-drug regimen approved for HIV—reducing patient exposure and potential drug interactions compared to usual pills containing three or more medicines The TGA has approved Dovato (dolutegravir and lamivudine), …

New proposals may see pharmacists dispensing downscheduled allergic rhinitis, migraine treatments, while caffeine powders are to be effectively banned The TGA’s medicine scheduling committee is set to rule on proposals …

New indication means budesonide/formoterol can be prescribed as needed (PRN) for patients with mild asthma, without daily maintenance treatment Symbicort Turbuhaler 200/6 and Symbicort Rapihaler 100/3 can now be prescribed …

PI documents for DOACs in Australia are being updated to include new information about increased risk of recurrent thrombotic events in a specific group of patients Pharmacists are advised that …